VILIMEKSO SISTEMA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 295,467 | 217,532 | 238,358 | 286,507 | 426,664 | 506,838 | 273,792 | 107,979 |
| Profit before tax | 70,501 | 47,176 | 28,011 | 87,078 | 106,783 | 97,351 | 9,264 | 111,451 |
| Net profit | 67,025 | 44,843 | 25,734 | 82,692 | 90,832 | 82,623 | 7,766 | 93,632 |
| Equity | 109,654 | 47,829 | 28,719 | 111,411 | 202,243 | 284,866 | 10,752 | 96,618 |
| Liabilities | 11,818 | 4,445 | 65,881 | 11,426 | 116,355 | 199,710 | 182,002 | 46,605 |
| Non-current assets | 19,146 | 13,581 | 8,295 | 3,284 | 127,770 | 193,113 | 169,897 | 17,000 |
| Current assets | 101,449 | 38,128 | 85,799 | 108,973 | 190,161 | 290,338 | 22,302 | 125,683 |
| Total assets | 120,595 | 51,709 | 94,094 | 112,257 | 317,931 | 483,451 | 192,199 | 142,683 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 112,164 | 80,876 | 4,581 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +62.6% | -26.4% | +9.6% | +20.2% | +48.9% | +18.8% | -46.0% | -60.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 55.6% | 86.7% | 27.3% | 73.7% | 28.6% | 17.1% | 4.0% | 65.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 61.1% | 93.8% | 89.6% | 74.2% | 44.9% | 29.0% | 72.2% | 96.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 22.7% | 20.6% | 10.8% | 28.9% | 21.3% | 16.3% | 2.8% | 86.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 23.9% | 21.7% | 11.8% | 30.4% | 25.0% | 19.2% | 3.4% | 103.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 2.3 | 0.1 | 0.6 | 0.7 | 16.9 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 147,734 | 62,152 | 69,763 | 95,502 | 165,162 | 168,946 | 91,264 | 53,990 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
VILIMEKSO SISTEMA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-08-17 | 2023-08-27 | 1.17 |
VILIMEKSO SISTEMA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
VILIMEKSO SISTEMA, UAB is a Private Limited Liability Company (code 123923460) operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €108.0K, down from €273.8K in 2024 and €506.8K in 2023, showing a marked two-year contraction in turnover. Despite the lower revenue base, profitability improved strongly in 2025: net profit reached €93.6K, compared with €7.8K in 2024 and €82.6K in 2023, resulting in an 86.7% profit margin. The latest year also shows very strong returns on capital, with ROE at 96.9% and ROA at 65.6%, while asset turnover stood at 0.76x.
At year-end 2025, total assets were €142.7K, equity €96.6K and liabilities €46.6K. The equity ratio was 67.7% and debt-to-equity 0.48, indicating a relatively conservative balance sheet structure. Revenue per employee was €54.0K and profit per employee €46.8K, suggesting strong productivity relative to the current scale of operations.
At year-end 2025, total assets were €142.7K, equity €96.6K and liabilities €46.6K. The equity ratio was 67.7% and debt-to-equity 0.48, indicating a relatively conservative balance sheet structure. Revenue per employee was €54.0K and profit per employee €46.8K, suggesting strong productivity relative to the current scale of operations.